Chicago, IL, United States of America

Nathan Tornquist

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathan Tornquist: Innovator in Skin Abnormality Monitoring

Introduction

Nathan Tornquist is an accomplished inventor based in Chicago, IL (US). He has made significant contributions to the field of dermatology through his innovative patent focused on skin abnormality monitoring systems and methods. His work aims to enhance the detection and classification of skin conditions, ultimately improving patient care.

Latest Patents

Nathan Tornquist holds a patent for a method of monitoring skin abnormalities on a skin portion of a patient. This method involves receiving first image data from an image capture device and identifying a first skin mask corresponding to the skin portion. The image data includes the skin portion and a first scaling element on the skin portion. The process further includes identifying one or more first keypoints within the first skin mask and classifying these keypoints, each of which represents an abnormality on the skin portion. This innovative approach has the potential to revolutionize how skin conditions are monitored and treated.

Career Highlights

Nathan Tornquist is currently associated with Skinio, LLC, where he applies his expertise in developing advanced skin monitoring technologies. His dedication to innovation in this field has positioned him as a key player in the dermatological research community.

Collaborations

Nathan collaborates with talented professionals such as Jean-Christophe Lapiere and Nicolas Longo, contributing to a dynamic team focused on advancing skin health technologies.

Conclusion

Nathan Tornquist's work in skin abnormality monitoring exemplifies the impact of innovation in healthcare. His patent and ongoing contributions are paving the way for improved diagnostic methods in dermatology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…